Auna SA(AUNA) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 4:00 PM ET (Korea 9/12 05:00)
Full metrics table
| Index | - | P/E | 94.69 | EPS (ttm) | 0.05 | Insider Own | 63.25% | Shs Outstand | 30.1M | Perf Week | -4.08% |
| Market Cap | 0.38B | Forward P/E | 4.7 | EPS next Y | 29.54% | Insider Trans | 0.14% | Shs Float | 27.2M | Perf Month | -0.58% |
| Enterprise Value | 1.39B | PEG | 1.61 | EPS next Q | 0.27 | Inst Own | 25.52% | Short Float | 2.3% | Perf Quarter | 4.44% |
| Income | 0.00B | P/S | 0.28 | EPS this Y | -34.81% | Inst Trans | -1.89% | Short Ratio | 3.24 | Perf Half Y | 3.82% |
| Sales | 1.36B | P/B | 0.7 | EPS next 5Y | 2.92% | ROA | 0.19% | Short Interest | 0.63M | Perf YTD | 5.08% |
| Book/sh | 7.37 | P/C | 2.71 | EPS past 3/5Y | - | ROE | 0.81% | 52W High | -24.53% ($6.85) | Perf Year | -18.84% |
| Cash/sh | 1.91 | P/FCF | 3.25 | Sales past 3/5Y | 24.37% 24.38% | ROIC | 0.27% | 52W Low | 26.41% ($4.09) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | 5.87 | EPS Y/Y TTM | -93.67% | Gross Margin | 36.89% | Volatility(W/M) | 2.31% 3.83% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 1.02 | Sales Y/Y TTM | 16.82% | Oper. Margin | 12.51% | ATR (14) | 0.16 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1 | EPS Q/Q | -61.75% | Profit Margin | 0.3% | RSI (14) | 47.18 | Recom | 1.4 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.08 | Sales Q/Q | 20.64% | SMA20 | -1.58% ($5.25) | Beta | 0.6 | Target Price | $7.67 |
| Payout | - | Debt/Eq | 2.01 | Earnings | 2026/8/18 | SMA50 | -0.58% ($5.2) | Rel Volume | 0.33 | Prev Close | $5.18 |
| Employees | 15254 | LT Debt/Eq | 1.77 | EPS/Sales Surpr. | -44.24% 2.57% | SMA200 | 2.21% ($5.06) | Avg Volume(3M) | 0.19M | Price | $5.17 |
| IPO | 2024/3/22 | Option/Short | No/Yes | Trades | 757 | Volume | 62,838 | Change | -0.19% |
Company
AUNA is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A Latin American healthcare facilities company operating hospital and clinic networks in Peru, Mexico, and Colombia, along with prepaid healthcare plans. It focuses on the treatment of complex conditions such as cancer (oncology), cardiac, and neurological diseases, while also offering a prevention-based model through Oncosalud, its prepaid healthcare plan in Peru.
Over the past 1 year, roughly in the middle
25% below its 1-year high.
AUNA makes money exceptionally well
12.51% of revenue is kept as operating profit.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -34.8% this year.
Tap to view numbers
The stock looks undervalued
Trading at 94.7 times earnings.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Long-term returns are close to the market
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 25.5%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
EPU 0.01%
BAMD 0.00%
HYEM 0.00%
EWX 0.00%It ranks #4 in the industry
Based on market cap of $383M.
AUNA $383M PER 94.7
HCA $92B PER 14.3
THC $21B PER 10.2
EHC $12B PER 19.8
FAQ
What kind of company is AUNA?
AUNA belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of AUNA?
The market cap of AUNA is approximately $383M, ranking 3,457 within its sector.
What is the P/E ratio of AUNA?
AUNA has a P/E ratio of approximately 94.7x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for AUNA?
AUNA has recorded a 52-week high of $6.85 and a low of $4.09.
